SCHEMBL13617800

SCHEMBL13617800

Nc1c(Cl)c(N2CCCC2)nc2c(Br)cnn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ CHEK1 O14757 2/20 0.36
▸ CCNA2 P20248 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ CCNA1 P78396 2/20 0.36
▸ ADORA2A P29274 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HPGD P15428 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545937 0.85 ADORA2A (0.42) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL14539517 0.83 KDR (0.38) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL11930843 0.82 HRH4 (0.38) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL11930848 0.82 HRH4 (0.38) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL14545940 0.81 SMPD3 (0.40) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL11930805 0.75 HRH4 (0.35) CHEK1CCNA2CDK2CCNA1
SCHEMBL11930845 0.75 CHEK1 (0.45) CHEK1CCNA2CDK2CCNA1
SCHEMBL15146129 0.74 ABL1 (0.38) ABL1KDRCHEK1CCNA2CDK2
SCHEMBL14545857 0.74 HRH4 (0.36) CDK2
SCHEMBL11930849 0.73 CHEK1 (0.43) ABL1KDRCHEK1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137378-A2 SEQUENTIAL ADMINISTRATION OF CHEMOTHERAPEUTIC AGENTS FOR TREATMENT OF CANCER SCHERING CORPORATION (US) 2009-11-12 — — WO disclosed
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback